Research Use Only. KIRhub outputs are computational research artifacts. They are not validated for clinical decision-making, diagnosis, or treatment.
KIRhub 2.0· v2Sign in
← Cases

ITK

RBC: ITK · Substrate: MBP ·

Top inhibitors

MeasuredDerived
DrugInhibition %Gini
Canertinib96.90.67
Ibrutinib94.50.72
Mobocertinib94.40.76
Repotrectinib88.00.61
Osimertinib85.40.73
Lazertinib84.00.67
Neratinib78.40.60
Zanubrutinib74.50.79
Dacomitinib73.60.66
Entrectinib68.40.67
Afatinib58.70.71
Nintedanib51.90.61
Ponatinib38.80.53
Brigatinib36.60.51
Sunitinib35.20.52

Known variants

No variants catalogued.
Open in new tab